Please login to the form below

Not currently logged in
Email:
Password:

Genentech

This page shows the latest Genentech news and features for those working in and with pharma, biotech and healthcare.

AZ says Brilinta hits the mark in new stroke trial

AZ says Brilinta hits the mark in new stroke trial

The currently only approved drug for the treatment of ischaemic stroke is Genentech’s tissue plasminogen activator (tPA) Activase (alteplase) – although this is a controversial therapy as it has an extremely

Latest news

More from news
Approximately 10 fully matching, plus 240 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 30 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics